FDA-Drug2026-07-01Class IIPACKAGING DEFECT

BD ChloraPrep Clear skin antiseptic recalled for sterility assurance due to packaging defect

TAMPERINGNationwide distributionDrugs

What this means

BD ChloraPrep Clear, a sterile skin antiseptic solution used before medical procedures, is being recalled because wrinkles in the paper packaging lid may allow the sterile seal to be breached. This defect could potentially allow contamination of the product. No injuries have been reported.

  • Check if you have BD ChloraPrep Clear applicators with lot numbers and expiration dates listed in the recall notice (June 2026 through May 2027).
  • Do not use recalled product; contact your healthcare facility, pharmacy, or BD customer service for replacement or guidance.
  • Healthcare facilities should quarantine affected inventory and review usage in medical procedures.
Get recalls like this in a free plain-English brief every Sunday.Get alerts ↓
The agency's original wording
Hazard

Lack of Assurance of Sterility: Due to wrinkles in the paper lidding which may breach the seal area.

Intended for
All ages
Illnesses reported
None reported
Sold states
Nationwide inthe USA, as well as other foreign distribution.
Affected count
N/A
Manufactured in
1550 Northwestern Dr, N/A, El Paso, TX, United States
Products
BD ChloraPrep Clear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) 1 mL Applicator, 60 Applicators, Sterile Solution, Care Fusion 213, LLC, El Paso, TX 79912, subsidiary of Beckton, Dickinson and Co., NDC 54365-400-31.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0622-2026

More CareFusion recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime
By signing up you agree to our Terms and Privacy Policy.